Metformin sensitizes EGFR-TKI-resistant human lung cancer cells in vitro and in vivo through inhibition of IL-6 signaling and EMT reversal (Q39014053)
Jump to navigation
Jump to search
scientific article published on 18 March 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Metformin sensitizes EGFR-TKI-resistant human lung cancer cells in vitro and in vivo through inhibition of IL-6 signaling and EMT reversal |
scientific article published on 18 March 2014 |
Statements
1 reference
Metformin sensitizes EGFR-TKI-resistant human lung cancer cells in vitro and in vivo through inhibition of IL-6 signaling and EMT reversal (English)
1 reference
Li Li
1 reference
Rui Han
1 reference
Hualiang Xiao
1 reference
Caiyu Lin
1 reference
Yubo Wang
1 reference
Hao Liu
1 reference
Kunlin Li
1 reference
Hengyi Chen
1 reference
Fenfen Sun
1 reference
Zhenzhou Yang
1 reference
Jianxin Jiang
1 reference
Yong He
1 reference
18 March 2014
1 reference
1 reference
Identifiers
1 reference